Colosseum Dental Group (CDG), a subsidiary of the Swiss-based Jacobs Holding, has successfully entered into a definitive agreement to acquire 100% of Curaeos. This transaction represents a transformative milestone in the group’s expansion strategy, creating the premier global dental services platform with approximately 800 clinics and over 13,000 professionals. The strategic rationale for the acquisition centers on the high degree of geographical complementarity between the two organizations, providing the group with immediate entry into the Belgian and Dutch markets while significantly densifying its existing leadership positions in Denmark, Italy, and Germany. By integrating the target’s scalable IT platform and vertically integrated laboratory network, the organization is poised to realize massive economies of scale and set new benchmarks for innovation within the European oral health sector. The partnership is designed to leverage combined medical and operational expertise to enhance patient care standards and professional development programs. This integration reinforces the organization's standing as a primary consolidator in the global healthcare landscape, providing the financial depth and strategic vision required to drive long-term value creation in non-cyclical, mission-critical service sectors.

This transaction is part of the Healthcare & Pharma industry, which currently tracks an average EBITDA multiple of 12.8x since the beginning of 2026, 1.8% increase compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.